Gender differences and worse metastatic survival outcomes in young adult patients with oesophagogastric cancer: 12year data from a Czech comprehensive cancer center

被引：0
|
作者：
Sokop, T. [1 ]
Selingerova, I. [2 ]
Obermannova, R. [3 ]
机构：
[1] Masaryk Univ, Dept Comprehens Canc Care, Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Masaryk Univ, Res Ctr Appl Mol Oncol, Masaryk Mem Canc Inst, Brno, Czech Republic
[3] Masaryk Univ, Dept Comprehens Canc Care, Masaryk Mem Canc Inst, Brno, South Moravian, Czech Republic
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1491
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1579P
引用
收藏
页码：S880 / S880
页数：1
相关论文
共 32 条
  • [31] Survival outcomes in patients (pts) with KRAS/NRAS (RAS) wild-type (WT) metastatic colorectal cancer (mCRC) and non-liver-limited disease (non-LLD): Data from the PRIME study.
    Douillard, Jean-Yves
    Tabernero, Josep
    Siena, Salvatore
    Peeters, Marc
    Koukakis, Reija
    Terwey, Jan-Henrik
    Sidhu, Roger
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Use of two-year disease-free survival (DFS) as a primary endpoint in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: New data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, NSAPB C-06 and C-07, and C89803
    Sargent, D. J.
    Yothers, G.
    Van Cutsem, E.
    Cassidy, J.
    Saltz, L.
    Wolmark, N.
    Shi, Q.
    Buyse, M.
    de Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
1234